Ishara Investments Lp Portfolio Stock Holdings
Ishara Investments Lp disclosed 36 stock positions valued at approximately $99.0 million in its latest SEC 13F filing. The largest holdings include PRAXIS PRECISION MEDICINES I, AXSOME THERAPEUTICS INC., and XERIS BIOPHARMA HOLDINGS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 36
- Portfolio Value
- $99.0M
Holdings by Sector
Ishara Investments Lp Portfolio Holdings in Q1 2026
34 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 7.34% | 22,550 | -17,450 | -43.63% | $7,265,385 |
| AXSOME THERAPEUTICS INC. | AXSM | Healthcare | 7.00% | 41,000 | +41,000 | +100.00% | $6,929,820 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | Healthcare | 6.00% | 1,025,000 | +225,000 | +28.13% | $5,945,000 |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 5.63% | 276,750 | +276,750 | +100.00% | $5,570,978 |
| AMICUS THERAPEUTIC | FOLD | Healthcare | 5.39% | 369,000 | +9,000 | +2.50% | $5,335,740 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 4.68% | 82,000 | -18,000 | -18.00% | $4,632,180 |
| VERASTEM INC | VSTM | Healthcare | 4.39% | 820,000 | +550,000 | +203.70% | $4,346,000 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 3.69% | 174,250 | +124,250 | +248.50% | $3,650,538 |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | Healthcare | 3.50% | 55,350 | +55,350 | +100.00% | $3,470,445 |
| VAXCYTE INC | PCVX | Healthcare | 3.37% | 57,400 | +7,400 | +14.80% | $3,335,514 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 3.33% | 82,000 | +82,000 | +100.00% | $3,298,860 |
| TRAVERE THERAPEUTICS INC | TVTX | Healthcare | 3.32% | 110,700 | +110,700 | +100.00% | $3,288,897 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 3.28% | 174,250 | +174,250 | +100.00% | $3,248,020 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | Healthcare | 2.91% | 1,230,000 | -90,000 | -6.82% | $2,878,200 |
| SCHOLAR ROCK HLDG CORP | SRRK | Healthcare | 2.85% | 57,400 | +57,400 | +100.00% | $2,821,784 |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 2.77% | 123,000 | -37,000 | -23.13% | $2,737,980 |
| ARDELYX INC | ARDX | Healthcare | 2.73% | 451,000 | +451,000 | +100.00% | $2,701,490 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 2.24% | 82,000 | +82,000 | +100.00% | $2,221,380 |
| GENMAB A/S | GMAB | Healthcare | 2.22% | 82,000 | +12,000 | +17.14% | $2,200,060 |
| CATALYST PHARMACEUTICALS INC | CPRX | Healthcare | 2.05% | 82,000 | +82,000 | +100.00% | $2,030,320 |
| SIONNA THERAPEUTICS INC | SION | Other | 1.99% | 49,200 | +49,200 | +100.00% | $1,972,428 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 1.87% | 142,000 | +142,000 | +100.00% | $1,854,520 |
| ALNYLAM PHARMACEUTICALS INC | ALNY | Healthcare | 1.71% | 5,125 | +5,125 | +100.00% | $1,695,709 |
| LIGAND PHARMACEUTICALS INC | LGND | Healthcare | 1.65% | 8,200 | +8,200 | +100.00% | $1,637,130 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 1.57% | 49,200 | -8,800 | -15.17% | $1,549,800 |
| LEXICON PHARMACEUTICALS INC | LXRX | Healthcare | 1.42% | 902,000 | +22,000 | +2.50% | $1,407,120 |
| BEAM THERAPEUTICS INC | BEAM | Healthcare | 1.38% | 57,400 | +7,400 | +14.80% | $1,367,842 |
| ORIC PHARMACEUTICALS INC | ORIC | Healthcare | 1.31% | 102,500 | -57,500 | -35.94% | $1,298,675 |
| NEWAMSTERDAM PHARMA COMPANY | NAMSW | Other | 1.19% | 36,900 | +6,900 | +23.00% | $1,181,169 |
| ANNEXON INC | ANNX | Healthcare | 0.97% | 174,250 | -575,750 | -76.77% | $965,345 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 0.83% | 24,600 | +24,600 | +100.00% | $819,672 |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 0.75% | 140,500 | -99,500 | -41.46% | $740,435 |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 0.71% | 10,250 | -25,750 | -71.53% | $698,333 |
| GOSSAMER BIO INC | GOSS | Healthcare | 0.27% | 820,000 | +820,000 | +100.00% | $269,370 |
Ishara Investments Lp Options Holdings in Q1 2026
1 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | PRAX | Praxis Precision Medicines, Inc | PUT | 20,500 | $6,604,895 |
Notional value represents the total exposure of the options position.